96 studies found for:    70806
Show Display Options
Rank Status Study
1 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
2 Suspended Vitamin D and Breast Cancer Biomarkers in Female Patients
Condition: Breast Cancer
Interventions: Dietary Supplement: vitamin D;   Other: placebo
3 Terminated
Has Results
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Conditions: Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: cetuximab;   Biological: bevacizumab
4 Active, not recruiting Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: adriamycin;   Drug: epirubicin;   Drug: fluorouracil
5 Active, not recruiting Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Sorafenib and Ixabepilone
6 Active, not recruiting A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Ixabepilone (Ixempra);   Drug: Paclitaxel (Taxol)
7 Completed
Has Results
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Imatinib;   Drug: Docetaxel
8 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
9 Active, not recruiting Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Biological: ziv-aflibercept;   Drug: topotecan hydrochloride
10 Completed
Has Results
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: RAD001
11 Active, not recruiting
Has Results
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Condition: Neoplasms, Breast
Interventions: Drug: Lapatinib;   Biological: Trastuzumab
12 Active, not recruiting A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: docetaxel;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: pegfilgrastim
13 Completed
Has Results
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Conditions: Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma
Intervention: Drug: belinostat
14 Completed An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
Condition: Healthy
Intervention:
15 Completed S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: paclitaxel;   Procedure: surgery
16 Completed
Has Results
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Radiation: radiation therapy
17 Active, not recruiting Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Conditions: Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sunitinib malate;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
18 Completed Exercise Trial for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Behavioral: Healthy Lifestyle Program;   Behavioral: Physical Activity Intervention
19 Completed
Has Results
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: irinotecan;   Drug: Carboplatin;   Drug: sunitinib
20 Completed Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Docetaxel/Carboplatin/Bevacizumab/Erlotinib;   Drug: Docetaxel/Carboplatin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years